Physician

Ashley Elizabeth Rosko, MD

According to 2025 Medicare claims, Ashley Rosko, MD (NPI: 1235339805) practices hematopoietic cell transplantation and cellular therapy in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is OSU INTERNAL MEDICINE, LLC (NPI: 1740231448; TIN: 311369596) and primary practice location at 43210-3100. Rosko is affiliated with the Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403) and CVS ACO (ACO ID: A5407), participating under the MSSP model.

Rosko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 241 traditional Medicare patients, billed 713 HCPCS/CPT codes, and received $39,450 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 259 prescription claims across 79 beneficiaries totaling $837,896 in drug costs, led by Venclexta (Venetoclax). 2023 DME data shows 25 claims. Open Payments data shows 5 records totaling $210,846. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $247,297 and ending at $837,896. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	138	525	$34,950
2016	204	695	$47,823
2017	223	650	$45,552
2018	279	704	$47,389
2019	238	637	$42,596
2020	246	595	$41,307
2021	267	561	$43,180
2022	252	528	$39,447
2023	254	544	$43,100
2024	241	713	$39,450

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	33	149	$247,297
2016	52	301	$499,857
2017	95	463	$818,640
2018	94	334	$1,044,809
2019	104	418	$1,617,140
2020	76	296	$1,164,352
2021	92	386	$1,381,079
2022	89	319	$1,028,074
2023	92	293	$576,262
2024	79	259	$837,896

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	15	$1,340
2018	N/R	71	$7,206
2019	28	117	$8,359
2020	N/R	66	$3,373
2021	N/R	64	$1,856
2022	N/R	41	$777
2023	N/R	25	$493
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	30	30	$123
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	12	13	$109
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	33	99	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	172	297	$66
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	135	228	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Venclexta	Venetoclax	31	924	$438,762
Ninlaro	Ixazomib Citrate	16	448	$208,019
Acyclovir	Acyclovir	42	2,580	$733
Dexamethasone	Dexamethasone	29	803	$218
Allopurinol	Allopurinol	17	570	$80

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$51	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	4	$210,795	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashley Elizabeth Rosko, MD?

Tedicare shows public-source Medicare data for Ashley Elizabeth Rosko, MD (NPI 1235339805), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashley Elizabeth Rosko, MD have ACO affiliation data?

Ashley Elizabeth Rosko, MD is shown with ACO affiliation data for Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403) and CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Ashley Elizabeth Rosko, MD?

Ashley Elizabeth Rosko, MD is linked to OSU INTERNAL MEDICINE, LLC (billing NPI 1740231448) in the available physician profile data.

Does Ashley Elizabeth Rosko, MD have Open Payments data?

Ashley Elizabeth Rosko, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.